Viewpoints / Position Papers

Home Scientific Strategy Viewpoints / Position Papers

As a leader in the fight against this disease, the Pancreatic Cancer Action Network provides information and commentary about scientific and medical topics.

Sutent© is the second targeted drug to be approved this month for the treatment of pancreatic neuroendocrine tumors

FOLFIRINOX shows encouraging results in pancreatic cancer

Novel noninvasive method for pancreatic cancer detection

Novartis drug approved to treat pancreatic neuroendocrine tumors

Two novel drugs recommended to be approved to treat pancreatic neuroendocrine tumors

Factors connecting inflammation to pancreatic cancer initiation and progression

Aspirin may decrease risk of pancreatic cancer

Malaria drug could be used to treat pancreatic cancer

Important genetic changes in pancreatic neuroendocrine tumors

Dr. Oz highlights pancreatic cancer on January 12th program

New test under development could detect single cancer cell in blood

New research suggests that pancreatic cancer growth rate may allow time for early detection

The Importance of Good Communication: Cell Signaling and How it Relates to Cancer

Consensus Report Offers Recommendations for Pancreatic Cancer Research Progress

Study Documents Significant Underuse of Surgical Resections

Grant Recipients Collaborate

Wage Hope With Us

Join us to double pancreatic cancer survival by 2020.





shop purple logo

Gear, apparel, accessories and more to show off your purple pride.


Shop Now 

©2018 Pancreatic Cancer Action Network. All rights reserved. Terms of Use | Privacy Policy


Pancreatic Cancer Action Network®, PanCAN®, PurpleStride®, Wage Hope®, Know Your Tumor®, Powerful Knowledge. Personal Treatment.®, Precision Promise℠ and Demand Better For Patients. For Survival.℠ are the trademarks of the Pancreatic Cancer Action Network, Inc.


The Pancreatic Cancer Action Network is registered as a 501©3 nonprofit organization. Contributions to the Pancreatic Cancer Action Network are tax-deductible to the extent permitted by law. The Pancreatic Cancer Action Network’s tax identification number is #33-0841281.